Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure - A substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure - A substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial
复制标题
DOI：
10.1161/01.cir.0000143059.68996.a7
复制
发表时间：
2004-09-28
期刊：
影响因子：
37.8
通讯作者：
Katus, HA
中科院分区：
文献类型：
--
作者：
Hartmann, F;Packer, M;Katus, HA
背景 - 在哥白尼（COPERNICUS）研究中，对N末端脑钠肽前体（NT - proBNP）预测死亡和住院发生情况的效用进行了前瞻性评估，该研究纳入了射血分数……的患者
Background-The utility of N-terminal proBNP (NT-proBNP) to predict the occurrence of death and hospitalization was prospectively evaluated in the COPERNICUS study, which enrolled patients with an ejection fraction